The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

European Journal of Cancer

Volumn 45, Issue 10, 2009, Pages 1780-1787

  Rakha, E A ^a   Aleskandarany, M ^a   El Sayed, M E ^a   Blamey, R W ^a   Elston, C W ^a   Ellis, I O ^a   Lee, A H S ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Histological grading; Human breast carcinoma; Inflammation; Medullary; Prognosis and outcome

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; FEMALE; HUMANS; INFLAMMATION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 66949168510     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.02.014     Document Type: Article

References (38)

1. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
2. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98 (2001) 10869-10874
3. Rakha E.A., Putti T.C., Abd El-Rehim D.M., et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208 (2006) 495-506
4. Jacquemier J., Padovani L., Rabayrol L., et al. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 207 (2005) 260-268
5. Rakha E.A., Reis-Filho J.S., and Ellis I.O. Basal-like breast cancer: a critical review. J Clin Oncol 26 (2008) 2568-2581
6. Ellis I.O., Galea M., Broughton N., Locker A., Blamey R.W., and Elston C.W. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20 (1992) 479-489
7. Pedersen L., Zedeler K., Holck S., Schiodt T., and Mouridsen H.T. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer 31A (1995) 2289-2295
8. Gaffey M.J., Mills S.E., Frierson H.F., et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol 8 (1995) 31-38
9. Anderson T.J., Sufi F., Ellis I.O., Sloane J.P., and Moss S. Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. Hum Pathol 33 (2002) 365-371
10. Pedersen L., Holck S., Schiodt T., Zedeler K., and Mouridsen H.T. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat 14 (1989) 91-99
11. Third Edition of the NHS Breast Screening Programme's Guidelines for Pathology Reporting in Breast Cancer Screening and the Second Edition of The Royal College of Pathologists' Minimum Dataset for Breast Cancer Histopathology. Sheffield; 2005.
12. Rilke F., Colnaghi M.I., Cascinelli N., et al. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer 49 (1991) 44-49
13. Lee A.H.S., Gillett C.E., Ryder K., Fentiman I.S., Miles D.W., and Millis R.R. Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology 48 (2006) 692-701
14. Baxevanis C.N., Dedoussis G.V., Papadopoulos N.G., Missitzis I., Stathopoulos G.P., and Papamichail M. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 74 (1994) 1275-1282
15. Venetsanakos E., Beckman I., Bradley J., and Skinner J.M. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. Br J Cancer 75 (1997) 1826-1830
16. Gabrilovich D.I., Corak J., Ciernik I.F., Kavanaugh D., and Carbone D.P. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3 (1997) 483-490
17. Davies B., Miles D.W., Happerfield L.C., et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67 (1993) 1126-1131
18. Nagaoka H., Iino Y., Takei H., and Morishita Y. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int J Oncol 13 (1998) 449-454
19. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
20. Pinder S.E., Ellis I.O., Galea M., O'Rouke S., Blamey R.W., and Elston C.W. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 24 (1994) 41-47
21. Bacus S., Flowers J.L., Press M.F., Bacus J.W., and McCarty K.S. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 90 (1988) 233-239
22. Blamey R.W., Ellis I.O., Pinder S.E., et al. Survival of invasive breast cancer according to the Nottingham prognostic index in cases diagnosed in 1990 to 1999. Eur J Cancer 43 (2007) 1548-1555
23. Shousha S. Medullary carcinoma of the breast and BRCA1 mutation. Histopathology 37 (2000) 182-185
24. Rodriguez-Pinilla S.M., Rodriguez-Gil Y., Moreno-Bueno G., et al. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: An immunohistochemical and gene amplification study. Am J Surg Pathol 31 (2007) 501-508
25. Li C.I., Uribe D.J., and Daling J.R. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93 (2005) 1046-1052
26. Bloom H.J., Richardson W.W., and Field J.R. Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 3 (1970) 181-188
27. Anderson W.F., Chu K.C., Chang S., and Sherman M.E. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13 (2004) 1128-1135
28. Gorski C.M., Niepolomska W., Novak K., et al. Clinical evaluation and pathological grading in relation to other prognostic factors. In: Forrest A.P.M., and Kunkler P.B. (Eds). Prognostic factors in breast cancer (1968), William and Wilkins, Baltimore, MD
29. Ridolfi R.L., Rosen P.P., Port A., Kinne D., and Mike V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 40 (1977) 1365-1385
30. Rapin V., Contesso G., Mouriesse H., et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 61 (1988) 2503-2510
31. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (2006) 1960-1964
32. Fiumara A., Belfiore A., Russo G., et al. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab 82 (1997) 1615-1620
33. Saleh F.H., Crotty K.A., Hersey P., Menzies S.W., and Rahman W. Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens. J Pathol 200 (2003) 383-395
34. Larsen S.U., and Rose C. Spontaneous remission of breast cancer. A literature review. Ugeskr Laeger 161 (1999) 4001-4004
35. McCoy J.L., Rucker R., and Petros J.A. Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status. Breast Cancer Res Treat 60 (2000) 227-234
36. Coventry B.J., Lee P.-L., Gibbs D., and Hart D.N.J. Dendritic cell density and activation status in human breast cancer - CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br J Cancer 86 (2002) 546-551
37. Iwamoto M., Shinohara H., Miyamoto A., et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104 (2003) 92-97
38. Lewis J.S., Landers R.J., Underwood J.C.E., Harris A.L., and Lewis C.E. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192 (2000) 150-158